Land: Verenigd Koninkrijk
Taal: Engels
Bron: HMA (Heads of Medicines Agencies)
cefquinome sulfate 150 mg/g
Virbac S.A.
QJ51DA92
Intramammary ointment
cefquinome
Cattle Non Lactating
2011-10-11
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Name of the product in FR: Cobactan DC Name of the product in UK/IE: Cephaguard DC 150 mg intramammary ointment All other CMS: Cobactan DC 150 mg intramammary ointment 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 3 g pre-filled syringe contains: ACTIVE SUBSTANCE Cefquinome (as sulphate): 150.0 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Intramammary ointment Homogeneous off-white oily ointment 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (dry cows) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of subclinical mastitis at drying off and the prevention of new bacterial infections of the udder during the dry period in the dairy cow caused by the following cefquinome sensitive organisms: _Streptococcus uberis, Streptococcus dysgalactiae, _ _Streptococcus agalactiae, Staphylococcus aureus, _coagulase negative staphylococci. 4.3 CONTRAINDICATIONS Not to be administered to animals which are known to be hypersensitive to cephalosporin antibiotics or other β-lactam antibiotics. Not to be administered to cows with clinical mastitis. And see section 4.7. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS USE OF THE PRODUCT SHOULD BE BASED ON SUSCEPTIBILITY TESTING OF THE BACTERIA ISOLATED FROM THE ANIMAL. IF IT IS NOT POSSIBLE, THERAPY SHOULD BE BASED ON LOCAL (REGIONAL, FARM LEVEL) EPIDEMIOLOGICAL INFORMATION ABOUT SUSCEPTIBILITY OF THE TARGET BACTERIA Do not use Lees het volledige document